BIOMARIN PHARMACEUTICAL INC·4

May 22, 4:36 PM ET

Hubbard Cristin 4

4 · BIOMARIN PHARMACEUTICAL INC · Filed May 22, 2024

Insider Transaction Report

Form 4
Period: 2024-05-20
Hubbard Cristin
EVP, Chief Commercial Officer
Transactions
  • Award

    Common Stock

    2024-05-20+4,70019,390 total
  • Award

    Common Stock

    2024-05-20+14,69014,690 total
  • Award

    Stock Option (Right to Buy Common Stock)

    2024-05-20+33,52033,520 total
    Exercise: $77.05From: 2025-05-20Exp: 2034-05-19Common Stock (33,520 underlying)
Footnotes (2)
  • [F1]Restricted stock units granted on May 20, 2024. Price not applicable.
  • [F2]Option grant vests 12/48th on May 20, 2025 and 1/48th on the 1st day of each month thereafter.

Documents

1 file
  • 4
    wk-form4_1716410173.xmlPrimary

    FORM 4